John Wherry News Today

The pandemic offered the first-ever opportunity for scientists to study how the immune system responds to a new threat, in real time, in the global population.

Explainer: Could The Omicron Variant Bring Milder Illness? : Rashtra News Omicron variant has prompted fears it could significantly undermine the effectiveness of vaccines.The Omicron variant, spreading now in southern Africa and detected in over 30 other countries, has prompted fears it could significantly undermine the effectiveness of vaccines against COVID-19.Yet as scientists race to

This year’s respiratory virus season is already looking different than last year’s — with Covid and flu both surging. Here's what to know.

Federal health officials and other experts have repeatedly sought to counter erroneous comments about the vaccines by Dr. Joseph Ladapo, Florida’s surgeon general.

/PRNewswire/ -- Marengo Therapeutics, Inc., a clinical-stage biotech company pioneering a new way to activate T cells by targeting germline-encoded alleles in...

Al Cross

Covid-19, influenza and respiratory syncytial virus (RSV) are circulating, so the vaccine season is upon us. To get the maximum protection, start with a game plan.

A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.

Faculty from the School of Arts & Sciences, School of Engineering and Applied Science, Graduate School of Education, and Perelman School of Medicine are recognized this year for contributions to physics, engineering and technology, education, economics, and microbiology and immunology.

Hybrid immunity, better treatment access, less severe infections helped control COVID